Rebecca Taub
Gründer bei MADRIGAL PHARMACEUTICALS, INC.
Vermögen: 412 Mio $ am 31.05.2024
Profil
Rebecca A.
Taub was the founder of Madrigal Pharmaceuticals, Inc. (founded in 2011) and held the title of Chief Executive Officer (2011) and Director, President-Research & Development (current).
She is also the founder of BriaCell Therapeutics Corp.
(current) where she serves as an Independent Director (2019).
Dr. Taub's former positions include Executive Director-CNS & Obesity Research at Bristol Myers Squibb Co. (2000-2003) and DuPont Pharmaceuticals Co. (2000-2003), Vice President-Research at Roche Pharmaceuticals, Inc., Professor at the University of Pennsylvania (1987-2002), Vice President-Research & Metabolic Diseases at Hoffmann-La Roche, Inc. (2004-2007), Associate Investigator at Howard Hughes Medical Institute, Inc., Senior Vice President-Research & Development at VIA Pharmaceuticals, Inc. (2008-2011), Assistant Professor at Harvard Medical School, and Professor at Perelman School of Medicine (1997-2001).
Dr. Taub's education includes a doctorate from Yale School of Medicine and an undergraduate degree from Yale College.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 22.04.2024 | 1 745 342 ( 8,19% ) | 412 Mio $ | 31.05.2024 | |
| 20.12.2023 | 0 ( -.--% ) | - $ | 31.05.2024 |
Aktive Positionen von Rebecca Taub
| Unternehmen | Position | Beginn |
|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. | Gründer | 01.07.2016 |
| BRIACELL THERAPEUTICS CORP. | Direktor/Vorstandsmitglied | 07.03.2018 |
Ehemalige bekannte Positionen von Rebecca Taub
| Unternehmen | Position | Ende |
|---|---|---|
| VIA PHARMACEUTICALS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2011 |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2008 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01.01.2003 |
DuPont Pharmaceuticals Co.
 DuPont Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology DuPont Pharmaceuticals Co. researches and develops pharmaceuticals and imaging products to treat diseases. It focuses on pharmaceuticals to treat unmet medical needs in the fight against HIV, cardiovascular disease, central nervous system disorders, cancer and arthritis-related disorders. The company is located in Wilmington, DE. | Corporate Officer/Principal | 01.01.2003 |
| University of Pennsylvania | Corporate Officer/Principal | 01.01.2002 |
Ausbildung von Rebecca Taub
| Yale School of Medicine | Doctorate Degree |
| Yale College | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| VIA PHARMACEUTICALS, INC. | Health Technology |
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| MADRIGAL PHARMACEUTICALS, INC. | Health Technology |
| BRIACELL THERAPEUTICS CORP. | Health Technology |
| Private Unternehmen | 5 |
|---|---|
Roche Pharmaceuticals, Inc.
 Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Roche Pharmaceuticals provides research and development services in the fields of pharmaceuticals and diagnostics. It also provides diagnostics and drugs for cancer and transplantation. The company is headquartered in Nutley, NJ. | Commercial Services |
DuPont Pharmaceuticals Co.
DuPont Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology DuPont Pharmaceuticals Co. researches and develops pharmaceuticals and imaging products to treat diseases. It focuses on pharmaceuticals to treat unmet medical needs in the fight against HIV, cardiovascular disease, central nervous system disorders, cancer and arthritis-related disorders. The company is located in Wilmington, DE. | Health Technology |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Health Technology |
Madrigal Pharmaceuticals, Inc. /Old/
 Madrigal Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Madrigal Pharmaceuticals, Inc. develops small-molecule drugs addressing major unmet needs in cardiovascular and metabolic diseases. It specializes in the treatment of both niche and prevalent indications, including fatty liver disease and non-alcoholic steatohepatitis, diabetes, dyslipidemia, and cardiovascular disease. The company was founded by Rebecca A. Taub, Brian N. Cunningham, and Edward Chiang in September 2011 and is headquartered in Fort Washington, PA. | Health Technology |
Howard Hughes Medical Institute, Inc.
 Howard Hughes Medical Institute, Inc. Investment Trusts/Mutual FundsMiscellaneous Howard Hughes Medical Institute, Inc. engages in the provision of biomedical research services and science education programs. It funds grants to both institutions and individuals in support of a wide range of science and research-related initiatives, including precollege and undergraduate science education, pre- and post-doctoral research fellowships, and international research activities. The company was founded by Howard R. Hughes in 1953 and is headquartered in Chevy Chase, MD. | Miscellaneous |
